Cabbacis to participate in Moody Capital Disruptive Growth conference
Cabbacis said management will participate in the Moody Capital Disruptive Growth & Life Sciences Conference.
Cabbacis (OTCQB: CABI), a U.S. federally-licensed tobacco-product manufacturer focused on risk-reduction products being developed under the iBLEND™ and X95™ brand names, today announced that management will participate in the Moody Capital Disruptive Growth & Life Sciences Conference, taking place…